NeuroPace, Inc. (NPCE) Financial Analysis & Valuation | Quarter Chart

NeuroPace, Inc. (NPCE)

NPCE
Price: $14.26
Fair Value: 🔒
🔒score
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system ... more
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS... more
Description Shares
Market Cap$480.09MExchangeNASDAQ
SectorHealthcareIndustryMedical - Devices
CountryUSCEOJoel D. Becker
IPO Date2021-04-22CAGR0.18%
Employees184Websitewww.neuropace.com
Div. YieldPayout Ratio
Buy Back Yield11.6%Total Yield11.6%
NPCE chart loading...
Fundamentals Technicals
Enterprise Value$569.83MP/E Ratio-21.61
Forward P/E-40.36PEG Ratio
P/S Ratio4.26P/B Ratio22.02
P/CF Ratio-38.07P/FCF Ratio-37.94
EPS$-0.66EPS Growth 1Y-30.53%
EPS Growth 3Y-65.62%EPS Growth 5Y-62.13%
Revenue Growth 1Y25.13%Gross Margin0.77%
Operating Margin-0.16%Profit Margin-0.32%
ROE-1.57%ROA-0.3%
ROCE-0.19%Current Ratio5.28
Quick Ratio4.33Cash Ratio1.22
Debt/Equity3.72Interest Coverage-1
Altman Z Score-2.78Piotroski Score3